First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors

Clinical trial NCT05828459 · RECRUITING

Trial details

NCT number: NCT05828459
Sponsor: Onward Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hematological Malignancy Solid Tumor

Start date: 2023-07-10
Primary completion: 2027-01-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.